Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers
- PMID: 3800343
- PMCID: PMC176512
- DOI: 10.1128/AAC.30.5.675
Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers
Abstract
Mezlocillin was previously reported to exhibit dose-dependent pharmacokinetics. These reports suggest that it may be possible to administer a relatively large dose at a longer interval than is usual and still achieve therapeutic concentrations in serum. In a randomized, crossover study, we compared concentrations of mezlocillin in serum after a single dose and at steady state in 12 healthy volunteers who received 4 g every 6 h and 5 g every 8 h. A slight, but statistically significant, dose-dependent effect was observed upon the area under the concentration-time curve and total body clearance. No accumulation was observed with either schedule. Although concentrations in serum were higher after the 5-g dose, the more frequent administration of the 4-g dose schedule produced serum concentrations above the MIC for susceptible bacteria for a greater portion of the day. In the absence of clear guidelines from human studies which relate serum concentrations to clinical response, the available data indicate that the more frequent dosage schedule is appropriate for severe infections.
Similar articles
-
Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.Antimicrob Agents Chemother. 1987 Jun;31(6):895-8. doi: 10.1128/AAC.31.6.895. Antimicrob Agents Chemother. 1987. PMID: 3619421 Free PMC article. Clinical Trial.
-
Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.Am J Med. 1988 Jul 25;85(1A):3-8. doi: 10.1016/0002-9343(88)90168-4. Am J Med. 1988. PMID: 3400680 Clinical Trial.
-
Developmental pharmacokinetics of mezlocillin in newborn infants.J Pediatr. 1984 May;104(5):773-81. doi: 10.1016/s0022-3476(84)80966-x. J Pediatr. 1984. PMID: 6716226
-
Review of the pharmacokinetics of mezlocillin.J Antimicrob Chemother. 1983 May;11 Suppl C:1-16. doi: 10.1093/jac/11.suppl_c.1. J Antimicrob Chemother. 1983. PMID: 6352604 Review. No abstract available.
-
Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.Clin Pharm. 1982 May-Jun;1(3):207-16. Clin Pharm. 1982. PMID: 6224627 Review.
Cited by
-
Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.Clin Pharmacokinet. 1989 Dec;17(6):385-95. doi: 10.2165/00003088-198917060-00003. Clin Pharmacokinet. 1989. PMID: 2689039 Review.
-
Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.Antimicrob Agents Chemother. 1987 Jun;31(6):895-8. doi: 10.1128/AAC.31.6.895. Antimicrob Agents Chemother. 1987. PMID: 3619421 Free PMC article. Clinical Trial.
-
Pharmacokinetics of two multiple-dose mezlocillin regimens.Antimicrob Agents Chemother. 1988 May;32(5):777-9. doi: 10.1128/AAC.32.5.777. Antimicrob Agents Chemother. 1988. PMID: 3395106 Free PMC article. Clinical Trial.
-
Pharmacokinetics of the acyclureidopenicillins piperacillin and mezlocillin in the postpartum patient.Antimicrob Agents Chemother. 1987 Dec;31(12):2015-7. doi: 10.1128/AAC.31.12.2015. Antimicrob Agents Chemother. 1987. PMID: 3439808 Free PMC article.
-
Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.Antimicrob Agents Chemother. 1987 Jun;31(6):925-9. doi: 10.1128/AAC.31.6.925. Antimicrob Agents Chemother. 1987. PMID: 3619425 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources